Working together to end the HIV epidemic.

There are approximately 39,000 people diagnosed with HIV in the US each year.1 HELP STOP THE VIRUS PRO is an initiative to support your work in helping to end the HIV epidemic. The Help Stop the Virus Pro website is designed to deliver insightful, current information about treatment trends and best practices.

Treat Asap

According to the DHHS Guidelines, treating HIV as soon as possible, regardless of CD4 count, is the standard of care. Treatment may be deferred on a case-by-case basis, as clinically appropriate.2

See what's recommended
Icon Treat with power

Consider a DHHS-recommended complete therapy based on a dual nucleoside reverse transcriptase inhibitor (NRTI) backbone plus an integrase inhibitor (INSTI).2

Find out more
Maintain suppression

Ongoing adherence to a prescribed regimen is essential for sustaining viral suppression.2 Regimens with simple administration, including low pill burden and no food requirement, help improve treatment adherence.2-5

Simplify administration

GET TREATMENT PERSPECTIVES FROM HIV SPECIALISTS

Video thumbnail Watch
BASELINE EVALUATIONS

Establish a baseline to help guide patient care

video thubmnail Watch
Treatment Goals

Set achievable HIV treatment goals

video thubmnail Watch
Adherence

Help patients remain on treatment

video thumbnail Watch
Secondary Transmission

Help prevent secondary transmission

REFERENCES:

  1. Centers for Disease Control and Prevention. HIV Surveillance Report, 2016; vol. 28. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published November 2017. Accessed July 7, 2018.
  2. US Department of Health and Human Services. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. https://aidsinfo.nih.gov/contentfiles/adultandadolescentgl.pdf. Updated May 30, 2018. Accessed June 4, 2018.
  3. Bangsberg DR, Ragland K, Monk A, Deeks SG. A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people. AIDS. 2010;24(18):2835-2840.
  4. Yager J, Faragon J, McGuey L, et al. Relationship between single tablet antiretroviral regimen and adherence to antiretroviral and non-antiretroviral medications among Veterans’ Affairs patients with human immunodeficiency virus. AIDS Patient Care STDs. 2017;31(9):370-376.
  5. Juday T, Grimm K, Zoe-Powers A, Willig J, Kim E. A retrospective study of HIV antiretroviral treatment persistence in a commercially insured population in the United States. AIDS Care. 2011;23(9):1154-1162.